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The goal of this review is to summarize current evidence for sex differences in the
response to cannabinoid compounds, focusing mainly on a specific age of exposure,
i.e., adolescence. Preclinical as well as clinical studies are examined. Among the different
possible underlying mechanisms, the consistent dimorphism in the endocannabinoid
system and delta9-tetrahydrocannabinol metabolism may play a part. All the collected
data point to the need of including females in basic research as well as of analyzing
results for sex differences in epidemiological studies.
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Introduction
Cannabis continues to be the most widely used illicit substance among adolescents in the world, and
more users are seeking treatment each year (1). Accumulating evidence suggests that exposure to
Cannabis or its psychoactive ingredient delta9-tetrahydrocannabinol (THC) during the adolescent
developmental window may act as a risk factor for the occurrence of psychiatric disorders later in
life (2–4).
Despite the well-accepted notion that several neuropsychiatric disorders, such as depression,
conduct problems, and autism, are sex-related [see, for review, Ref. (5–7)], very few papers have
dealt with sex vulnerability to adolescent Cannabis abuse, both at the preclinical and clinical
level. The main obstacle to this lies in the fact that research is still mainly focused on the male
sex: male animals in preclinical research and male subjects in clinical studies. The potential sex
influence is still routinely ignored or dismissed even when both sexes are included, as in some
human studies where no sex-related analysis is performed, but all the subjects are regarded as
“unisex.” Fortunately, the view that biological sex is unimportant in neuroscience is increasingly
seen as a false assumption [see for a commentary Ref. (8)]. Notably, the National Institute of
Health has recently asked the scientific community for sex and gender inclusion plans in preclinical
research (9).
We hope from now on to witness an increasing amount of research considering both sexes.
However, so far, few papers have dealt with the influence of this variable on the response to
cannabinoids during adolescence. Most work has been done at the preclinical level, but some
literature on humans is now also appearing. For the sake of accuracy, in this review we will take
into account only papers where both male and females are considered, or papers applying exactly
the same paradigm of exposure in male and female animals.
Human Studies
Few studies exist on sex-dependent effects of adolescent Cannabis abuse in humans, so it is
difficult to draw a precise picture of this phenomenon. Nonetheless, here we want to discuss
some interesting observations. Generally, Cannabis use is more prevalent among males, who
display an earlier age of onset of use and are more likely to be on a heavier use trajectory (10).
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As a consequence, males appear to be more likely than females
to become dependent on Cannabis (11, 12). However, females
tend to have shorter intervals between the onset of use and reg-
ular use or development of dependence (13, 14). Accordingly,
females enter treatment for Cannabis use disorders after fewer
years and less cumulative use compared to males (15). In gen-
eral, Cannabis abuse is associated with a broad range of adverse
health measures in both adolescent girls and boys (14). The
existence of an overall sex-dependent effect has already been
reported for other drugs of abuse (16), and specifically, female
adolescent users seem to experience negative consequences of
drug use earlier than male peers, and appear to be more likely
to suffer from an internalizing disorder, such as depressive and
anxiety disorders (16). Conversely, male substance abusers have
more externalizing behaviors, such as aggressiveness and impul-
sivity (16). This seems to be true also for Cannabis. One of
the first papers describing this correlation reported that daily
Cannabis use was associated with a fivefold increase in anxiety
and depression in young females, but not males (17). Accordingly,
higher rates of comorbid mood and anxiety disorders in women
have been recently observed in a large epidemiological study
performed in the United States (18). Adolescent female abusers,
who developed greater internalizing symptoms, exhibited larger
right amygdala volumes relative to males and female controls
(19). Interestingly, larger amygdala volumes were associated with
increased depression and anxiety symptomatology (19). Similarly,
Lai and Sitharthan (20) reported a significant association between
Cannabis use disorder and mental health disorders, and again,
higher comorbidity rates were observed for females. The most
common mental disorders were major depression, personality
disorder, schizophrenia, and severe stress disorder (20). Poten-
tial sex-differences have also been reported for Cannabis use
and neurocognitive functioning (21). Specifically, Cannabis use
was more consistently associated with poorer episodic memory
performance in females and with poorer decision-making per-
formance in males. Female Cannabis users presented a larger
prefrontal cortex (PFC) volume compared to controls, whereas
male users presented a smaller one (22). It is worth noting that
among users, larger PFC total volume was associated with worse
executive functioning, thus implying that females performed
the worst. Finally, studying the association between Cannabis
use and earlier age of onset of psychosis (AOP), researchers
found that male users are the group with the earliest AOP.
However, this seems to be independent of sex, and instead
linked to the fact that males start first and consume more than
females (23).
In conclusion, Cannabis abuse in humans appears to be asso-
ciated with different responses in male and females, resembling
what has already been seen with other drugs of abuse. The
molecular bases of these sex differences need further inves-
tigation. Future studies should take into account the inter-
action between the endocannabinoid system and sex hor-
mones, but also the fact that adolescent males and females
undergo neuromaturation at separate rates, thus presenting
differential trajectories of neuronal maturation at the same
age (24, 25), that could hence be differently affected by
Cannabis.
Animal Studies
Animal models, although far from addressing the complexity
of human disorders, allow experimental controls that are not
possible in human studies. Moreover, they provide a valuable
approach for the investigation of neurobiological substrates.
Through this helpful tool, it has been confirmed that chronic
administration of natural or synthetic cannabinoids during the
adolescent period – using paradigms resembling heavy Cannabis
abuse in humans – causes persistent behavioral alterations in
adult animals [see, for review, Ref. (2, 4, 26)]. Cognition is one
of the most explored brain functions after adolescent exposure
to natural or synthetic cannabinoids. When sex was taken into
account, it appeared that cannabinoid exposure during adoles-
cence impaired learning and memory in both sexes. O’Shea et al.
(27, 28) demonstrated that adolescent exposure to increasing
doses of the synthetic cannabinoid agonist CP-55,940 for 21 days
induced impaired recognition memory in the novel object recog-
nition test long after discontinuation of the drug, in both female
and male rats. However, when spatial memory was assessed in the
Morris water maze test, adolescent cannabinoid exposure in both
sexes disrupted learning immediately after the treatment (29), but
not after a long drug-free period (29, 30). In the active place avoid-
ance (APA) paradigm, where animal’s ability to learn and retrieve
spatial information as well as flexibility of learning is assessed,
early adolescent THC exposure did not affect the task acquisition,
nor the performance after the 24-h retention interval in adult
animals of both sexes (31). However, when flexibility was consid-
ered, impaired performance on the reversal trial of the APA task
was observed (31). In the radial maze test, used to assess spatial
workingmemory, bothmale and female rats showed deficits when
tested long after adolescent exposure to THC (32, 33). These data
suggest that adolescent exposure to cannabinoids induces long-
term cognitive impairments specifically in recognition and spatial
working memory, as well as in flexibility, whereas pure spatial
memory does not seem to be affected. However, these effects do
not display sex differences, since they are present in both male
and female animals. Less consistent results have been obtained
about the impact of adolescent cannabinoid treatment on anxiety
behaviors. In fact, results coming from adult animals of both sexes
exposed to cannabinoids during their adolescence showed all type
of responses: anxiolytic-like response (34), anxiogenic-like effect
(27, 28), or no changes in their behavior (35). Neither conclusions
regarding the impact of adolescent exposure on anxiety behaviors
nor about possible sex differences can be drawn from these find-
ings. A different picture is present when the forced swim test was
used: adolescent exposure to THC induced a significant increase
in immobility that was apparent only in female rats (35, 36). Also,
the effect of adolescent cannabinoid exposure on adult drug self-
administration seems to present sex-dependency. Higher adult
cocaine self-administration rates have been reported in female
rats only (37), whereas increase in morphine self-administration
under the fixed ratio 1 schedule has been described in males
but not in females (38). As a whole, animal models seem to
confirm the existence of some sex-dependent responses to adoles-
cent cannabinoid exposure, with females appearingmore sensitive
than males in the emotional sphere.
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These differences in behavior are substantiated by differences
at the cellular/molecular level. Pharmacokinetics seems to play
a part. It has been recently reported that adolescent female
rats exhibit pronounced metabolism of THC to the still active
compound 11-OH-THC compared to their male conspecifics,
particularly after repeated THC administration (39). Thus, THC
exposure could conceivably be potentiated by its active metabolite
in female adolescents. This fact together with the observation
that adolescent female rats possess more efficient CB1 receptors
(40), suggests that they may be more vulnerable to THC effects.
Accordingly, chronic THC exposure in adolescence inducedmore
intense CB1 receptor desensitization in females, with more brain
areas involved, despite similar down-regulation (35, 41). If con-
firmed also in humans, this would explain, at least in part, why
females tend to have shorter intervals between the onset of use
and the development of dependence, the so-called “telescoping
effect” (13–15, 18). Another observation that comes from animal
studies and deserves further investigation is that sex-dependent
sensitivity appears to exist also with regard to the brain regions
that are affected by the treatment. Specifically, in female ani-
mals, among all the cerebral areas investigated, the PFC seems
to be the most affected, whereas it is the hippocampus in males.
For example, Higuera-Matas et al. (30) reported that while peri-
adolescent exposure to a fixed dose of a synthetic cannabinoid
agonist did not produce robust behavioral effects, it did induce an
increase of the plasticity marker PSA-NCAM in the hippocampus
of males only. Similarly, Lee et al. (42) showed that a sustained
adolescent CB1 receptor activation reduced adult hippocam-
pal neurogenesis in both sexes; however, for some parameters,
males appeared to be more greatly affected than females. Our
group, in the search for a possible molecular correlate for the
impaired spatial working memory induced by adolescent THC
administration, investigated some markers of neuroplasticity in
the PFC and hippocampus of both male and female rats (32,
33). Interestingly, a significant decrease in pre- and post-synaptic
markers was present in the hippocampus of male rats, whereas
the same proteins changed in the PFC of female animals (32,
33). Of note, in human Cannabis abusers, the occurrence of
significant changes in the hippocampus of males (43) and in
the PFC and amygdala of females (19, 22) have been observed.
These brain regions are differently involved in the modulation of
cognition (hippocampus and PFC) and emotion (amygdala and
PFC), and this may explain the greater effect on emotionality in
females.
Conclusion
In conclusion, some sex-dependent effects exist in the response
to cannabinoid compounds between adolescent males and
females. These effects may rely on the different pharmacokinetics
described for THC between males and females as well as on sex
differences present in the endocannabinoid system. To complicate
the picture, a fact that is specific for the adolescent population and
should also be taken into account is represented by the observa-
tion that some brain developmental characteristics are different
in the two sexes. For example, neurodevelopmental trajectories
are significantly different between males and females [(25); see,
for review, Ref. (44)]. Total brain size and regional gray matter
volumes follow an inverted U shaped maturational curve and
peak earlier in females, thus suggesting that the pruning process
occurring in the adolescent brain might be present with different
intensity in boys and girls of the same age. Since it has been
recently suggested that the endocannabinoid system in the adoles-
cent brain may play a part in synaptic pruning (45), exposure to
cannabinoids during adolescence might differently interact with
the pruning event in boys and girls, thus leading to different
impairments in brain and behavior. Not least, interactions of the
endocannabinoid system with gonadal hormones may also play
a part. Interestingly, it has been recently suggested that sex hor-
mones and the endocannabinoid systemmight work in symphony
to promote maturational processes within the adolescent brain,
specifically in those circuits important for the emotional and
motivational response to sexually relevant stimuli (46). However,
the existence of a close interaction between the endocannabinoid
system and sex hormones has long been known. For example, CB1
receptor expression and density appear to be under the control of
sex steroids in both males and females in some cerebral areas (47,
48). More recently, it has been reported that endocannabinoids
and gonadal hormones may reciprocally regulate each other, and
interestingly, estrogen can recruit endocannabinoids to modu-
late emotionality (49, 50). This is particularly important when
considering that ovarian hormones may actively contribute to
the remodeling event in the female brain during puberty and
adolescence, as recently suggested by Juraska et al. (51). This
was demonstrated for few brain areas; among them, there are
the PFC and amygdala, the very same areas mainly affected by
cannabinoids in adolescent females. A deeper knowledge of all
these interactions would be helpful in designing proper sex-
specific treatments or interventions to prevent or recover the
long-term adverse effects induced by adolescent heavy Cannabis
abuse.
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